# A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis

> **NCT03423121** · PHASE1,PHASE2 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 59 (actual)

## Conditions studied

- Progressive Multiple Sclerosis

## Interventions

- **DRUG:** Tauroursodeoxycholic Acid
- **DRUG:** Placebo oral capsule

## Key facts

- **NCT ID:** NCT03423121
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-19
- **Primary completion:** 2022-04-28
- **Final completion:** 2022-07-05
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03423121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03423121, "A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03423121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*